The Journal of Immunology, Vol 151, Issue 4 2077-2086, Copyright © 1993 by American Association of Immunologists

ARTICLES

Targeted activation of CD8 cells and infection of beta 2-microglobulin- deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis

ZE Wang, SL Reiner, F Hatam, FP Heinzel, J Bouvier, CW Turck and RM Locksley
Department of Medicine, UCSF 94143-0654.

CD8+ T cells play an important role in the immunologic control of intracellular pathogens, particularly viruses. Leishmania are obligate intracellular parasites of macrophages in the mammalian host, and previous studies using deletion of CD8+ cells by administration of mAb to infected animals have suggested a protective role for these cells. Two complementary approaches were used to define more carefully the role of CD8+ cells in leishmaniasis. In BALB/c mice susceptible to Leishmania major (L. major) infection, targeted activation of CD8+ T cells was attempted by immunization with nonapeptides derived from the conserved major outer surface protein of the organism, gp63, that contained the consensus binding motif for MHC class I H-2Kd molecules. Two of the nonapeptides induced CTL activity in subsequently infected BALB/c mice that could be elicited against P815 cells pulsed either with peptide or lysates of L. major. Purified CD8+ T cells from immunized mice had elevated levels of IFN-gamma mRNA transcripts as compared to unimmunized mice. Despite evidence for activation of CD8+ cells, none of the mice immunized with nine different peptides alone or in combination were protected from progressive disease. In a second series of experiments, beta 2-microglobulin deficient mice that lack CD8+ cells were infected with L. major and the course of infection monitored. These mice cured disease as rapidly as beta 2-m +/- and +/+ littermates, and cure was associated with comparable levels of IFN- gamma mRNA in the draining lymph node population. Neither of these approaches was able to confirm a substantive role for CD8+ T cells in the primary protective response to L. major.

This article has been cited by other articles:

				G. Bomfim, B. B. Andrade, S. Santos, J. Clarencio, M. Barral-Netto, and A. Barral Cellular Analysis of Cutaneous Leishmaniasis Lymphadenopathy: Insights into the Early Phases of Human Disease Am J Trop Med Hyg, November 1, 2007; 77(5): 854 - 859. [Abstract] [Full Text] [PDF]

				J. C. Cooper, G. B. Dealtry, M. A. Ahmed, P. C. Arck, B. F. Klapp, S. M. Blois, and N. Fernandez An Impaired Breeding Phenotype in Mice with a Genetic Deletion of Beta-2 Microglobulin and Diminished MHC Class I Expression: Role in Reproductive Fitness Biol Reprod, August 1, 2007; 77(2): 274 - 279. [Abstract] [Full Text] [PDF]

				R. Polley, S. Stager, S. Prickett, A. Maroof, S. Zubairi, D. F. Smith, and P. M. Kaye Adoptive Immunotherapy against Experimental Visceral Leishmaniasis with CD8+ T Cells Requires the Presence of Cognate Antigen Infect. Immun., January 1, 2006; 74(1): 773 - 776. [Abstract] [Full Text] [PDF]

				J. L. Amprey, J. S. Im, S. J. Turco, H. W. Murray, P. A. Illarionov, G. S. Besra, S. A. Porcelli, and G. F. Spath A Subset of Liver NK T Cells Is Activated during Leishmania donovani Infection by CD1d-bound Lipophosphoglycan J. Exp. Med., October 4, 2004; 200(7): 895 - 904. [Abstract] [Full Text] [PDF]

				J. E. Uzonna, K. L. Joyce, and P. Scott Low Dose Leishmania major Promotes a Transient T Helper Cell Type 2 Response That Is Down-regulated by Interferon {gamma}-producing CD8+ T Cells J. Exp. Med., June 7, 2004; 199(11): 1559 - 1566. [Abstract] [Full Text] [PDF]

				M. Colmenares, P. E. Kima, E. Samoff, L. Soong, and D. McMahon-Pratt Perforin and Gamma Interferon Are Critical CD8+ T-Cell-Mediated Responses in Vaccine-Induced Immunity against Leishmania amazonensis Infection Infect. Immun., June 1, 2003; 71(6): 3172 - 3182. [Abstract] [Full Text] [PDF]

				Y. Belkaid, E. Von Stebut, S. Mendez, R. Lira, E. Caler, S. Bertholet, M. C. Udey, and D. Sacks CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major J. Immunol., April 15, 2002; 168(8): 3992 - 4000. [Abstract] [Full Text] [PDF]

				S. Mendez, S. Gurunathan, S. Kamhawi, Y. Belkaid, M. A. Moga, Y. A. W. Skeiky, A. Campos-Neto, S. Reed, R. A. Seder, and D. Sacks The Potency and Durability of DNA- and Protein-Based Vaccines Against Leishmania major Evaluated Using Low-Dose, Intradermal Challenge J. Immunol., April 15, 2001; 166(8): 5122 - 5128. [Abstract] [Full Text] [PDF]

				S. Gurunathan, L. Stobie, C. Prussin, D. L. Sacks, N. Glaichenhaus, D. J. Fowell, R. M. Locksley, J. T. Chang, C.-Y. Wu, and R. A. Seder Requirements for the Maintenance of Th1 Immunity In Vivo Following DNA Vaccination: A Potential Immunoregulatory Role for CD8+ T Cells J. Immunol., July 15, 2000; 165(2): 915 - 924. [Abstract] [Full Text] [PDF]

				F. P. Heinzel and R. M. Rerko Cure of Progressive Murine Leishmaniasis: Interleukin 4 Dominance Is Abolished by Transient CD4+ T Cell Depletion and T Helper Cell Type 1-selective Cytokine Therapy J. Exp. Med., June 21, 1999; 189(12): 1895 - 1906. [Abstract] [Full Text] [PDF]

				E. Y. Denkers and R. T. Gazzinelli Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588. [Abstract] [Full Text] [PDF]

				M. Huber, E. Timms, T. W. Mak, M. Rollinghoff, and M. Lohoff Effective and Long-Lasting Immunity against the Parasite Leishmania major in CD8-Deficient Mice Infect. Immun., August 1, 1998; 66(8): 3968 - 3970. [Abstract] [Full Text] [PDF]

				K. Swier, D. R. Brown2, J. J. Bird, W. D. Martin, L. V. Kaer, and S. L. Reiner Cutting Edge: A Critical, Invariant Chain-Independent Role for H2-M in Antigen Presentation J. Immunol., January 15, 1998; 160(2): 540 - 544. [Abstract] [Full Text] [PDF]

				S. L. Reiner, D. J. Fowell, N. H. Moskowitz, K. Swier, D. R. Brown, C. R. Brown, C. W. Turck, P. A. Scott2, N. Killeen, and R. M. Locksley3 Control of Leishmania major by a Monoclonal {alpha}{beta} T Cell Repertoire J. Immunol., January 15, 1998; 160(2): 884 - 889. [Abstract] [Full Text] [PDF]

				D. R. Brown, K. Swier, N. H. Moskowitz, M. F. Naujokas, R. M. Locksley, and S. L. Reiner T Helper Subset Differentiation in the Absence of Invariant Chain J. Exp. Med., January 1, 1997; 185(1): 31 - 42. [Abstract] [Full Text] [PDF]

				E Mougneau, F Altare, A. Wakil, S Zheng, T Coppola, Z. Wang, R Waldmann, R. Locksley, and N Glaichenhaus Expression cloning of a protective Leishmania antigen Science, April 28, 1995; 268(5210): 563 - 566. [Abstract] [PDF]